Related references
Note: Only part of the references are listed.Imaging the Impact of the P-Glycoprotein (ABCB1) Function on the Brain Kinetics of Metoclopramide
Geraldine Pottier et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Local Drug-Drug Interaction of Donepezil with Cilostazol at Breast Cancer Resistance Protein (ABCG2) Increases Drug Accumulation in Heart
Ryota Takeuchi et al.
DRUG METABOLISM AND DISPOSITION (2016)
The Concept of Fraction of Drug Transported (f(t)) With Special Emphasis on BBB Efflux of CNS and Antiretroviral Drugs
B. Prasad et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2015)
Overcoming the blood-brain tumor barrier for effective glioblastoma treatment
O. van Tellingen et al.
DRUG RESISTANCE UPDATES (2015)
Approaching complete inhibition of P-glycoprotein at the human blood-brain barrier: an (R)-[11C]verapamil PET study
Martin Bauer et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2015)
Quantitative Analysis of the ABCG2 c.421C>A Polymorphism Effect on In Vivo Transport Activity of Breast Cancer Resistance Protein (BCRP) Using an Intestinal Absorption Model
Yuta Tanaka et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2015)
Factors Governing P-Glycoprotein-Mediated Drug-Drug Interactions at the Blood-Brain Barrier Measured with Positron Emission Tomography
Thomas Wanek et al.
MOLECULAR PHARMACEUTICS (2015)
Increased Permeability-Glycoprotein Inhibition at the Human Blood-Brain Barrier Can Be Safely Achieved by Performing PET During Peak Plasma Concentrations of Tariquidar
William C. Kreisl et al.
JOURNAL OF NUCLEAR MEDICINE (2015)
Using Positron Emission Tomography to Study Transporter-Mediated Drug-Drug Interactions in Tissues
B. Wulkersdorfer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2014)
Inhibiting drug efflux transporters improves efficacy of ALS therapeutics
Michael R. Jablonski et al.
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY (2014)
Why Clinical Modulation of Efflux Transport at the Human Blood-Brain Barrier Is Unlikely: The ITC Evidence-Based Position
J. C. Kalvass et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2013)
Interaction of 11C-Tariquidar and 11C-Elacridar with P-Glycoprotein and Breast Cancer Resistance Protein at the Human Blood-Brain Barrier
Martin Bauer et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Interindividual variability in the hepatic expression of the human breast cancer resistance protein (BCRP/ABCG2): Effect of age, sex, and genotype
Bhagwat Prasad et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Quantitative Atlas of Blood-Brain Barrier Transporters, Receptors, and Tight Junction Proteins in Rats and Common Marmoset
Yutaro Hoshi et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Assessment of cerebral P-glycoprotein expression and function with PET by combined [11C]inhibitor and [11C]substrate scans in rats
Julia Muellauer et al.
NUCLEAR MEDICINE AND BIOLOGY (2013)
Tariquidar and Elacridar Are Dose-Dependently Transported by P-Glycoprotein and Bcrp at the Blood-Brain Barrier: A Small-Animal Positron Emission Tomography and In Vitro Study
Jens P. Bankstahl et al.
DRUG METABOLISM AND DISPOSITION (2013)
Pgp-Mediated Interaction Between (R)-[11C]Verapamil and Tariquidar at the Human Blood-Brain Barrier: A Comparison With Rat Data
M. Bauer et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2012)
A novel PET protocol for visualization of breast cancer resistance protein function at the blood-brain barrier
Thomas Wanek et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2012)
The Specific P-Glycoprotein Inhibitor Tariquidar Is Also a Substrate and an Inhibitor for Breast Cancer Resistance Protein (BCRP/ABCG2)
Pavitra Kannan et al.
ACS CHEMICAL NEUROSCIENCE (2011)
Breast Cancer Resistance Protein and P-Glycoprotein in Brain Cancer: Two Gatekeepers Team Up
Sagar Agarwal et al.
CURRENT PHARMACEUTICAL DESIGN (2011)
Quantitative targeted absolute proteomics of human blood-brain barrier transporters and receptors
Yasuo Uchida et al.
JOURNAL OF NEUROCHEMISTRY (2011)
Evaluation of Limiting Brain Penetration Related to P-glycoprotein and Breast Cancer Resistance Protein Using [11C]GF120918 by PET in Mice
Kazunori Kawamura et al.
MOLECULAR IMAGING AND BIOLOGY (2011)
Transcriptomic and Quantitative Proteomic Analysis of Transporters and Drug Metabolizing Enzymes in Freshly Isolated Human Brain Microvessels
Ramzi Shawahna et al.
MOLECULAR PHARMACEUTICS (2011)
Synthesis and evaluation of [11C]XR9576 to assess the function of drug efflux transporters using PET
Kazunori Kawamura et al.
ANNALS OF NUCLEAR MEDICINE (2010)
Synthesis and in vivo evaluation of [11C]tariquidar, a positron emission tomography radiotracer based on a third-generation P-glycoprotein inhibitor
Florian Bauer et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2010)
Regional P-Glycoprotein Activity and Inhibition at the Human Blood-Brain Barrier as Imaged by Positron Emission Tomography
S. Eyal et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Dose-response assessment of tariquidar and elacridar and regional quantification of P-glycoprotein inhibition at the rat blood-brain barrier using (R)-[11C]verapamil PET
Claudia Kuntner et al.
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING (2010)
P-Glycoprotein Function at the Blood-Brain Barrier in Humans Can Be Quantified with the Substrate Radiotracer 11C-N-Desmethyl-Loperamide
William C. Kreisl et al.
JOURNAL OF NUCLEAR MEDICINE (2010)
Kinetic Analysis of the Cooperation of P-Glycoprotein (P-gp/Abcb1) and Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting the Brain and Testis Penetration of Erlotinib, Flavopiridol, and Mitoxantrone
Hiroshi Kodaira et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2010)
ABCG2 Polymorphism Markedly Affects the Pharmacokinetics of Atorvastatin and Rosuvastatin
J. E. Keskitalo et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2009)
An Unexpected Synergist Role of P-Glycoprotein and Breast Cancer Resistance Protein on the Central Nervous System Penetration of the Tyrosine Kinase Inhibitor Lapatinib (N-{3-Chloro-4-[(3-fluorobenzyl)oxy]phenyl}-6-[5-({[2(methylsulfonyl)ethyl]amino}methyl)-2-furyl]-4-quinazolinamine; GW572016)
Joseph W. Polli et al.
DRUG METABOLISM AND DISPOSITION (2009)
Synthesis and Small-Animal Positron Emission Tomography Evaluation of [11C]-Elacridar As a Radiotracer to Assess the Distribution of P-Glycoprotein at the Blood-Brain Barrier
Bernd Doerner et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
Imaging of Cyclosporine Inhibition of P-Glycoprotein Activity Using 11C-Verapamil in the Brain: Studies of Healthy Humans
Mark Muzi et al.
JOURNAL OF NUCLEAR MEDICINE (2009)
Pharmacogenetic characterization of sulfasalazine disposition based on NAT2 and ABCG2 (BCRP) gene polymorphisms in humans
Y. Yamasaki et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Several major antiepileptic drugs are substrates for human P-glycoprotein
Carlos Luna-Tortos et al.
NEUROPHARMACOLOGY (2008)
Quantitative atlas of membrane transporter proteins:: Development and application of a highly sensitive simultaneous LC/MS/MS method combined with novel in-silico peptide selection criteria
Junichi Kamiie et al.
PHARMACEUTICAL RESEARCH (2008)
P-glycoprotein and breast cancer resistance protein: Two dominant transporters working together in limiting the brain penetration of topotecan
Nienke A. de Vries et al.
CLINICAL CANCER RESEARCH (2007)
Pharmacoresistance in epilepsy:: A pilot PET study with the p-glycoprotein substrate R-[11C]verapamil
Oliver Langer et al.
EPILEPSIA (2007)
Imaging P-glycoprotein transport activity at the human blood-brain barrier with positron emission tomography
L Sasongko et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Functional assessment of ABCG2 (BCRP) gene polymorphisms to protein expression in human placenta
D Kobayashi et al.
DRUG METABOLISM AND DISPOSITION (2005)
Three-dimensional maximum probability atlas of the human brain, with particular reference to the temporal lobe
A Hammers et al.
HUMAN BRAIN MAPPING (2003)
Effect of efflux inhibition on brain uptake of itraconazole in mice infected with Cryptococcus neoformans
F Imbert et al.
DRUG METABOLISM AND DISPOSITION (2003)
Share Paper
